CRISPR THERAPEUTICS AG

Ticker: CRSP CUSIP: H17182108 Class: NAMEN AKT

SFE Investment Counsel's Holding History (CIK: 0001317784)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 12,600 Value ($000) $661 Avg Close $59.89 Range $48.02 - $78.48
Q3 2025
Shares 11,560 Value ($000) $749 Avg Close $57.41 Range $46.60 - $71.13
Q2 2025
Shares 7,232 Value ($000) $352 Avg Close $38.70 Range $30.04 - $51.52
Q1 2025
Shares 6,507 Value ($000) $221 Avg Close $42.39 Range $32.96 - $55.88
Q4 2024
Shares 6,152 Value ($000) $242 Avg Close $47.22 Range $38.20 - $59.07
Q3 2024
Shares 6,312 Value ($000) $297 Avg Close $50.74 Range $43.42 - $63.68
Q2 2024
Shares 5,846 Value ($000) $316 Avg Close $57.84 Range $51.02 - $68.39
Q1 2024
Shares 5,643 Value ($000) $385 Avg Close $71.59 Range $58.29 - $91.10
Q4 2023
Shares 4,900 Value ($000) $307 Avg Close $55.02 Range $37.55 - $76.97